A two-step FIB-4 plus VCTE approach effectively stratifies liver fibrosis and liver-related event risk in type 2 diabetes with MASLD. Prevalence of MASLD was 71.3% and significant fibrosis 21.1% in older outpatients.
A study from the University of Osaka identified the integrin αV–YAP–CTGF pathway linking chronic liver congestion to fibrosis. The findings point to a potential therapeutic target in congestion-related liver disease.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07797673 |
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia |
NOT_YET_RECRUITING | PHASE1 |
| NCT07610837 |
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis |
RECRUITING | PHASE2 |
